Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.423ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.423ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.423EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.423EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.423ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.423ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.281EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.281EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.281ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.281ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.281EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.281EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.281ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.281ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AE.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AE.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AE.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AE.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AE.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AE.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.230EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.230EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.230ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.230ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.230EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.230EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.230ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.230ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.53EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.1.53ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.53ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.1.53EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.1.53EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.1.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.1.450EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.450EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.450ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.450ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.450EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.450EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.450ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.450ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.334EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.334EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.334ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.334ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used